Eye Disease
Cyclosporine 0.09% improved dry eye signs in patients previously treated with 0.05%
Twice-daily cyclosporine ophthalmic emulsion 0.09% significantly improved signs of dry eye disease in patients who were inadequately controlled with cyclosporine ophthalmic emulsion 0.05%, according to a study presented at SECO 2025.
More than 4 million U.S. adults have glaucoma, about 35% have related vision loss
An estimated 4.22 million U.S. adults had glaucoma in 2022, and 1.49 million had vision-affecting glaucoma, with “substantial variation” in prevalence by region and demographics, according to a study published in JAMA Ophthalmology.
Single TearCare treatment improves visual function, quality of life in dry eye disease
Patients who underwent a single treatment with TearCare experienced significant improvements in reading speed, as well as signs and symptoms of dry eye disease, 1 month after the procedure, according to a study in Clinical Ophthalmology.
Researchers identify gene linked to inherited retinal dystrophy
The loss of UBAP1L gene function appears to be associated with nonsyndromic retinal dystrophy, according to research published in JAMA Ophthalmology.
Aldeyra resubmits reproxalap NDA for treatment of dry eye
Aldeyra Therapeutics has resubmitted a new drug application for topical reproxalap for the treatment of signs and symptoms of dry eye disease, the company announced in a press release.
Q&A: 72% of eye drop medication wasted due to ‘self-imposed use cessation dates’
Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.
Fenofibrate reduces progression of diabetic eye disease
ORLANDO — The generic lipid-lowering drug fenofibrate was associated with a significant reduction in progression of diabetic retinopathy and maculopathy, researchers reported.
WCO launches Competency Framework for Optometry
The World Council of Optometry has announced the launch of its Competency Framework for Optometry, a resource designed to define essential skills, knowledge and abilities for the profession and streamline optometric education worldwide.
Eversight partners with Emmecell to advance corneal epithelial cell therapies
The nonprofit eye bank Eversight has partnered with Emmecell, a clinical-stage biotechnology company, to advance therapies involving donor corneal epithelial cells for treatment of eye disease.
Diagnose dry eye in a few simple steps
Even if your practice is pressed for time, you have time to diagnose dry eye disease, treat it and track your results. Diagnosis doesn’t take a lot of extra equipment — just simple steps you can fit into a basic exam.